Skip to main content

Peer Review reports

From: Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study

Original Submission
27 Jul 2021 Submitted Original manuscript
27 Sep 2021 Reviewed Reviewer Report - Joerg Trojan
23 Oct 2021 Reviewed Reviewer Report
30 Nov 2021 Author responded Author comments - Yee Chao
Resubmission - Version 2
30 Nov 2021 Submitted Manuscript version 2
13 Dec 2021 Author responded Author comments - Yee Chao
Resubmission - Version 3
13 Dec 2021 Submitted Manuscript version 3
Publishing
24 Dec 2021 Editorially accepted
11 Jan 2022 Article published 10.1186/s12885-022-09173-4

You can find further information about peer review here.

Back to article page